Article ; Online: Clinical characteristics of SARS-CoV-2 infection in children with cystic fibrosis: An international observational study.
Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society
2020 Volume 20, Issue 1, Page(s) 25–30
Abstract: ... for children with CF, their families, caregivers and clinical teams.: Methods: Cases of SARS-CoV-2 infection ... attributed to COVID-19 disease.: Conclusions: SARS-CoV-2 infection in children with CF is usually ... identified as a risk factor for severe COVID-19 disease. Information on the clinical course of SARS-CoV-2 ...
| Abstract | Background: The presence of co-morbidities, including underlying respiratory problems, has been identified as a risk factor for severe COVID-19 disease. Information on the clinical course of SARS-CoV-2 infection in children with cystic fibrosis (CF) is limited, yet vital to provide accurate advice for children with CF, their families, caregivers and clinical teams. Methods: Cases of SARS-CoV-2 infection in children with CF aged less than 18 years were collated by the CF Registry Global Harmonization Group across 13 countries between 1 February and 7 August 2020. Results: Data on 105 children were collated and analysed. Median age of cases was ten years (interquartile range 6-15), 54% were male and median percentage predicted forced expiratory volume in one second was 94% (interquartile range 79-104). The majority (71%) of children were managed in the community during their COVID-19 illness. Out of 24 children admitted to hospital, six required supplementary oxygen and two non-invasive ventilation. Around half were prescribed antibiotics, five children received antiviral treatments, four azithromycin and one additional corticosteroids. Children that were hospitalised had lower lung function and reduced body mass index Z-scores. One child died six weeks after testing positive for SARS-CoV-2 following a deterioration that was not attributed to COVID-19 disease. Conclusions: SARS-CoV-2 infection in children with CF is usually associated with a mild illness in those who do not have pre-existing severe lung disease. |
||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| MeSH term(s) | Adolescent ; COVID-19/complications ; COVID-19/epidemiology ; COVID-19/therapy ; Child ; Cystic Fibrosis/complications ; Cystic Fibrosis/epidemiology ; Cystic Fibrosis/therapy ; Disease Progression ; Female ; Humans ; Male ; Prognosis ; Risk Factors ; SARS-CoV-2 | ||||||||||
| Language | English | ||||||||||
| Publishing date | 2020-12-03 | ||||||||||
| Publishing country | Netherlands | ||||||||||
| Document type | Journal Article ; Multicenter Study ; Observational Study ; Research Support, Non-U.S. Gov't | ||||||||||
| ZDB-ID | 2084724-5 | ||||||||||
| ISSN | 1873-5010 ; 1569-1993 | ||||||||||
| ISSN (online) | 1873-5010 | ||||||||||
| ISSN | 1569-1993 | ||||||||||
| DOI | 10.1016/j.jcf.2020.11.021 | ||||||||||
| Shelf mark |
|
||||||||||
| Database | MEDical Literature Analysis and Retrieval System OnLINE |
Full text online
More links
Kategorien
In stock of ZB MED Cologne/Königswinter
| Zs.A 6028: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular ab Jg. 2022: Lesesaal (EG) |
|||
| Zs.MO 459: Show issues |
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.